Events2Join

Performance Reporting for the Prescription Drug Rebate Program


Medicaid Drug Rebate Program Data

The rebate drug product data contains the active drugs that have been reported by participating drug manufacturers as of the most recent rebate reporting period ...

Medicaid Drug Rebate Program (MDRP)

The Medicaid Drug Rebate Program (MDRP) is a program that includes Centers for Medicare & Medicaid Services (CMS), state Medicaid agencies, ...

Manufacturer Rebate Summary Report - CMS

Restricted to rebates associated with Part D drug events in calendar year 2014. Excludes non-rebate amounts reported as "other direct and ...

Performance Reporting for the Prescription Drug Rebate Program

This report details the outstanding prescription drug rebate balances for the Texas Medicaid Program, Children's Health. Insurance Program (CHIP) ...

Part C and D Performance Data - CMS

Hospice Quality Reporting Program · Long-Term ... Prescription drug assistance programs ... Drug pricing & rebate review. Close this menu.

Performance Reporting for the Prescription Drug Rebate Program

This report details the outstanding prescription drug rebate balances for the Texas Medicaid Program,. Children's Health Insurance Program (CHIP) ...

Developing Performance Measures for Prescription Drug Management

The demand for accountability and a means to evaluate performance of drug benefit management programs is growing; nevertheless, a set of valid, standardized ...

CMS Releases Final Rule on the Medicaid Drug Rebate Program

The Centers for Medicare & Medicaid Services (CMS) on Sept. 20, 2024, released the Misclassification of Drugs, Program Administration and ...

Survey of Potential Drug Rebates Associated With Drugs ...

However, for prescription drugs that are funded through a separate CHIP, the Federal Medicaid Drug Rebate Program (MDRP) requirements currently do not apply.

Understanding the Medicaid Prescription Drug Rebate Program - KFF

Certain pediatric and clotting drugs have a lower rebate amount of 17.1% (Figure 1). Best price is defined as the lowest available price to any ...

State Agencies Could Be Obtaining Hundreds of Millions in ...

We reviewed each of our 57 previous OIG audits of the Medicaid drug rebate program and summarized the results of those audits for this report.

Reports - Vendor Drug Program

Annual Performance Report for the Prescription Drug Rebate Program. Published Nov. 2023. 2022. Performance Reporting for the Prescription Drug Rebate Program ( ...

A primer on Medicare Part D prescription drug rebates - Milliman

CMS: Because Part D rebates are shared with CMS, the federal government's liability for the Part D program is also affected by rebates. The more ...

Trends of Prescription Drug Manufacturer Rebates in Commercial ...

Rebate% was measured as a plan's total pharmaceutical rebate divided by its total prerebate prescription drug costs. All dollar amounts were ...

Medicaid Program – Improper Payments for Drugs Without a Federal ...

The Medicaid Drug Rebate Program (MDRP) helps to offset the costs of most covered outpatient drugs dispensed to Medicaid patients. The MDRP ...

HHSC Publishes Annual Performance Report for the Prescription ...

HHSC Publishes Annual Performance Report for the Prescription Drug Rebate Program ... Children with Special Health Care Needs (CSHCN) Services ...

Insights into why rebates are a target for reducing prices - Milliman

Prescription drug rebates are generally paid by a pharmaceutical manufacturer to a PBM, who then shares a portion with the health insurer.

Social Security Act §1927

PAYMENT FOR COVERED OUTPATIENT DRUGS. Sec. 1927. [42 U.S.C. 1396r–8] (a) Requirement for Rebate Agreement.—. (1) In general.—In order for payment to be ...

PCN 15-04 Utilization and Reporting of Pharmaceutical Rebates

Ryan White HIV/AIDS Program (RWHAP) Part B AIDS Drug Assistance Programs. (ADAP) that collect rebates on ADAP medication purchases. This policy replaces the. “ ...

CMS Issues the Long-Awaited Medicaid Drug Rebate Program Final ...

Under the MDRP, manufacturers must report and certify to CMS certain drug product and drug pricing information for CODs to support the ...